Hong Kong-listed biotech stocks jumped on Thursday. TYK Medicines surged over 15%, while Sirnaomics climbed more than 13%. CanSino Biologics rose more than 7%, Everest Medicines and Akeso advanced about 5%.
The rally comes amid renewed investor interest in the healthcare sector, driven by expectations of policy support and ongoing innovation momentum.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.